0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Medical News & Perspectives

JAMA. 1991;266(6):757-768. doi:10.1001/jama.1991.03470060015002.
Text Size: A A A
Published online

ABSTRACT

FDA 'Pushing Envelope' on AIDS Drug  THE FOOD and Drug Administration (FDA) is "pushing the envelope" of drug development with its review of didanosine (DDI, Bristol-Myers Squibb Co, New York, NY), says FDA commissioner David Kessler, MD."This represents a milestone in drug review," he says. Just 3½ months after the company submitted its new drug application, the agency's antiviral advisory committee voted five to two to recommend approval for adult and pediatric patients with the acquired immunodeficiency syndrome (AIDS) who no longer respond to zidovudine (AZT, Burroughs Wellcome Co, Research Triangle Park, NC), the only licensed AIDS drug.The agency will act on the recommendation by the committee of outside experts in as short a time as possible, says Kessler.Another milestone was achieved by the agency's internal reviewers, who applied "innovative, sophisticated models" in analyzing uncontrolled data from phase I trials and an expanded-access compassionate distribution program,

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();